Exempts all retail sales of mobility enhancing equipment from sales and use tax.
Summary
S1509 would expand New Jersey’s sales and use tax exemption for mobility enhancing equipment by removing the current requirement that the equipment be sold pursuant to a doctor’s prescription. Under the bill, all retail sales of qualifying mobility enhancing equipment would be exempt from sales tax, whether or not a prescription is involved. The bill keeps the existing statutory definition of mobility enhancing equipment, which covers items primarily used to improve movement and mobility, such as walkers, wheelchairs, canes, crutches, lift chairs, patient lifts, grab bars, and wheelchair ramps.
The measure also preserves the broader structure of the state’s medical-related sales tax exemptions in N.J.S.A. 54:32B-8.1, which already covers items such as prescription drugs, over-the-counter drugs, diabetic supplies, prosthetic devices, medical oxygen, and durable medical equipment for home use. The bill would take effect immediately, but the tax exemption for mobility enhancing equipment would apply only to sales occurring on or after the first day of the third month following enactment.
Impact
The bill would amend the Sales and Use Tax Act to broaden an existing exemption by eliminating the prescription prerequisite for mobility enhancing equipment. As a result, retailers selling qualifying mobility aids would no longer need to verify a doctor’s prescription to treat the sale as tax-exempt, and consumers purchasing these items would pay no sales tax on eligible purchases. The change would affect both sellers and purchasers of mobility-related products, while leaving the definition of qualifying equipment and the tax treatment of medical service supplies otherwise unchanged.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of legislative debate or formal support/opposition in the available record. Based on the bill’s text and statement, the measure appears to be framed as a consumer relief and accessibility expansion for people who use mobility aids. The overall tone of the proposal is straightforward and remedial, suggesting a generally favorable policy purpose rather than a controversial restructuring of tax law.
Contention
The main policy issue is the removal of the doctor’s prescription requirement. Supporters would likely view that change as reducing administrative burden and making mobility aids more affordable and accessible for people with disabilities, seniors, and others with limited mobility. Any opposition would likely focus on the revenue impact of expanding the exemption and on whether removing the prescription gate could broaden the exemption beyond the original medical necessity standard. No specific objections, amendments, or competing viewpoints are documented in the provided materials.